Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Chylothorax
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
Accumulation of chyle in the pleural space ''(chylous ascites, chylous pericardial effusion)'' == '''Aetiology''' == * Traumatic ** Blunt ** Penetrating * Iatrogenic ** Catheterisation, particularly subclavian vein ** Post-surgical (damage to thoracic duct) ** Excision of cervical/supraclavicular lymph nodes ** Radical lymph node dissections of the neck or chest ** Lung, oesophageal or mediastinal resection ** Thoracic aneurysm repair ** Sympathectomy ** Congenital cardiovascular surgery * Neoplasms ** Lymphoma, lung, oesophageal or mediastinal neoplasms ** Metastatic carcinoma * Infectious ** Tuberculous lymphadenosis ** Mediastinitis ** Ascending lymphangitis * Other ** Lymphangioleiomyomatosis ** Venous thrombosis ** Congenital == '''Pathophysiology''' == * Extravasation from the thoracic duct * Chyle ** A milky white fluid with a high concentration of triglycerides and chylomicrons and white blood cells ** Majority from dietary fat absorption, most of which is in the form of long chain fatty triglycerides ** Short and medium chain triglycerides are mostly absorbed through portal venous system and hence don't affect thoracic duct flow as much ** Chylomicrons travel through the lymphatic system over the course of several hours after a meal, and are then deposited into the venous system ** Nutritionally rich, depending on the nutritional and dietary status of the patient ** Can be clear * Causes loss of fat and protein which often causes nutritional problems ** Malnutrition - loss of energy, fat, and fat-soluble vitamins, and immunoglobulin and immune cells ** Immune compromise (increased risk of bacterial infection) ** Impaired wound healing * Volume of leak typically 0.5-3L per day ** Increased by peristalsis and even water intake ** However chyle output mainly comes from long chain triglycerides * Chyle does not contain fibrinogen, so even small injuries to the duct will not heal == '''Presentation''' == * Dyspnoea/cough * Milky white chest tube output - usually becomes evident after diet/feeds introduced * Neutropaenia, lymphocytopaenia, antibody loss, infection/sepsis, albumin loss, malnutrition == '''Diagnosis''' == * Triglyceride level of drain output - a level >1.2mmol/L is diagnostic of a chyle leak * Chylomicrons is gold standard but takes longer to come back == '''Management''' == * '''Approach''' ** Treat underlying condition ** Manage nutrition ** Low-output chylothorax (<1L/day) - often medical chylothorax or minor trauma to thoracic duct/tributaries - step-up approach with initial medical management, unless you suspect that won't work ** High-output chylothorax (>1L/day) - often surgical injuries to main thoracic duct or cirrhosis - early intervention, within a few days of diagnosis, is often favoured, as these injuries are less likely to heal spontaneously * '''Nutritional management''' (from Austin chyle leak guidelines 2023) ** All patients need dietician involvement and nutritional assessment - identify pre-existing malnutrition, and prescribe an appropriate nutritional regimen to minimise chyle flow and maintain residual nutritional requirements ** Consider energy losses from chyle output (840kJ/L) and protein losses (20-30g/L) ** There are no RCTs which demonstrate an acceptable dietary fat intake to promote healing of the injury. Austin guideline says to give <20g long chain triglycerides per day for 3 weeks (or 2 weeks after resolution of the leak). UTD says aim <10g fat/day. ** Monitor for signs of essential fatty acid deficiency if on fat-free diet for >2 weeks (skin lesions, eczema, impaired wound healing, thrombocytopenia) ** '''Well-nourished patients with chyle leak <1000mL/day''' *** Trial fat-free oral diet *** Fat-free nutritional supplements to meet energy and protein requirements *** Use some MCT oil/supplements to help meet requirements, but can't rely on them too much, as they cause GIT upset **** Oral: MCT oil (on PBS) - 4tbs/24 hours **** Oral or enteric: MCT procal - 5 sachets per day or Betaquik - 5x50mL doses/day *** If patients don't respond to a modified oral diet, TPN may be warranted, but in that case keep going with some enteral feeds ** '''Malnourished patients with chyle leak <1000mL/day''' *** Enteral feeding with fat-free formula up to two weeks *** After two weeks, need to change to low-fat elemental formula which contains a small amount of LCT to meet essential fatty acid and fat-soluble vitamin requirements (e.g. Vivonex) *** If patients not responding, TPN may be warranted ** '''Chyle leak >1000mL/day''' *** NBM with TPN to meet full nutritional requirements - enteral nutrition is unlikely to make much difference *** Can give TPN with impunity, as the phospholipid constituents pass directly into the venous circulation * '''Other components of conservative management''' ** Drainage of pleural space *** Unnecessary with asymptomatic non-surgical patients with small effusions, unless symptomatic; patients with chylous ascites; and early post-op pneumonectomy patients without mediastinal shift *** Intermittent thoracentesis is appropriate for patients with medical chylothorax and slow reaccumulation ** Octreotide/somatostatin *** Inhibits gastric, pancreatic and biliary secretions, and inhibit absorption of chyle from the intestine *** Increases the probability of avoiding surgical repair in patients with low-volume leaks on TPN, as shown in systematic reviews *** Some suggest giving from the start with low-volume leaks, while others advise giving as a second-line therapy *** Limit to a trial of a few weeks *** Can be given subcutaneously (50-200mcg TDS for 2-14 days) or intravenous infusion (6mg/day for two weeks) ** Ensure lung is fully expanded ** When drainage is <250mL/day, challenge with a fatty meal * '''Surgery''' ** '''Indications''' (all relative) *** Failed conservative management *** High-output chylothorax (>1L/day) *** Some say, aim to operate between day 7 and 14 *** Suspected or known injury to main thoracic duct, as opposed to tributaries (less likely to settle with conservative management) *** Older, frail or malnourished patients who may tolerate a trial of conservative management worse ** '''Technique''' *** Right thoracotomy or thoracoscopy and ligation of thoracic duct at level of diaphragm **** Place olive oil or ice cream via NGT intra-operatively to increase chyle leak and aid identification of leak point **** Can try suture ligation, clipping, gluing, flap coverage, or pleurodesis *** Emerging percutaneous techniques involving radiological needle cannulation and duct occlusion == '''Prognosis''' == * 50-80% of post-op chylothorax resolves with conservative measures, with a high success rate in patients with <500mL/day [[Category:Thoracics]]
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Chylothorax
Add topic